0001213900-20-016315.txt : 20200630 0001213900-20-016315.hdr.sgml : 20200630 20200630161444 ACCESSION NUMBER: 0001213900-20-016315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200626 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bell John K CENTRAL INDEX KEY: 0001569585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 201002482 MAIL ADDRESS: STREET 1: 38 FALLBROOK LANE RR 33 CITY: CAMBRIDGE STATE: A6 ZIP: N3H 4R8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 ownership.xml X0306 4 2020-06-26 1 0001498382 DelMar Pharmaceuticals, Inc. DMPI 0001569585 Bell John K 12707 HIGH BLUFF DR. SUITE 200 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2020-06-30 4 J 0 29 0 A 9817 I Held by Onbelay Capital Inc. Common Stock 35000 I Held by Registered Retirement Income Fund Options (Right to Buy) 0.61 2020-06-26 4 A 0 39567 0 A 2029-09-05 Common Stock 39567 75000 D The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020. The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019. The reporting person did not stand for reelection at the 2020 Annual Meeting of Stockholders and ceased to be a director on June 26, 2020. /s/ Anthony Scott Praill, attorney-in-fact for John K. Bell 2020-06-30